Market news

Detailed price information for IM Cannabis Corp (IMCC-Q) from The Globe and Mail including charting and trades.

U.S. stocks fell Wednesday, led by a 1.1% Nasdaq drop. Cintas beat estimates and raised guidance; oil gained while gold, silver and copper declined.

IM Cannabis stock reverses an earlier surge after a $1.31 million share offering followed its non-binding defense-tech deal.

Gainers IM Cannabis (NASDAQ:IMCC) stock rose 56.3% to $6.47 during Wednesday's pre-market session. The company's market cap stands at $2.5 million. Vistagen Therapeutics (NASDAQ:VTGN) shares increased by

IM Cannabis Corp. ("IMCC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announced the closing of a US$225,000 convertible note financing in a private placement with an institutional investor (the "Lender").

Detailed price information for IM Cannabis Corp (IMCC-Q) from The Globe and Mail including charting and trades.

IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, announces that, further to its press release dated August 18, 2026, the Company's common shares, no par value per share ("Common Shares"), commenced trading today on the Nasdaq Capital Market LLC ("Nasdaq") on a 30:1 post-consolidated basis (the "Consolidation").

IM Cannabis (NASDAQ:IMCC) has entered into a definitive agreement to sell IMC Holdings and its European-focused assets to Slil. com Holding, a transaction management expects to improve shareholders’ equity by approximately C$3 million while reducing liabilities and simplifying the company’s structure.

TORONTO and GLIL YAM, Israel, Aug. 17, 2026/ PRNewswire/-- IM Cannabis Corp., today announced that, further to its press release dated June 18, 2026, it has entered into a definitive share purchase agreement dated August 16, 2026 with Slil.com Holding Ltd. and I.M.C. Holdings Ltd. pursuant to which the Company has agreed to sell to Slil all of the issued and outstanding...

TORONTO and GLIL YAM, Israel, Aug. 13, 2026/ PRNewswire/-- IM Cannabis Corp., today announced its financial results for the three and six months ended June 30, 2026. Revenue of $16.3 million, compared to $25.2 million in the same period in 2025. Gross profit of $2.9 million, compared to $6.9 million in the same period in 2025. Operating loss of $3.8 million, compared to...

Detailed price information for IM Cannabis Corp (IMCC-Q) from The Globe and Mail including charting and trades.

Tipranks Press Release.

TORONTO and GLIL YAM, Israel, July 27, 2026/ PRNewswire/-- IM Cannabis Corp., a medical cannabis company with operations in Israel and Germany, announces that Mr. Alon Dayan has resigned as a director of the Company for personal reasons. The board of directors and management of IM Cannabis thank Mr. Dayan for his service and valuable contributions to the Company...